InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the detailed record of transactions filed by SALUCK RANDY S., Director. Director active across 1 company, notably Statera Biopharma, Inc.. Cumulatively, 1 disclosures have been logged. Activity tracked since 9 September 2021. The latest transaction was disclosed on 9 September 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Randy S. Saluck is a Board Member at Statera Biopharma, Inc. He provides expertise and guidance to steer the company's strategic decisions. His role is essential to ensure compliance and performance within the organization.